Induction of erythropoiesis by hypoxia-inducible factor prolyl hydroxylase inhibitors without promotion of tumor initiation, progression, or metastasis in a VEGF-sensitive model of spontaneous breast cancer
Hypoxia · 2017
DOI: 10.2147/hp.s130526 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hypoxia, 2017. Verfasst von Todd W Seeley und 4 weiteren Autor:innen. Beteiligte Einrichtung: Therapeutics R&D, FibroGen, Inc., San Francisco, CA, USA. Die Arbeit wurde bisher 52-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Therapeutics R&D, FibroGen, Inc., San Francisco, CA, USA.
Zitieren
APA
Seeley, T. W., Sternlicht, M. D., Klaus, S. J., Neff, T. B., & Liu, D. Y. (2017). Induction of erythropoiesis by hypoxia-inducible factor prolyl hydroxylase inhibitors without promotion of tumor initiation, progression, or metastasis in a VEGF-sensitive model of spontaneous breast cancer. Hypoxia. https://doi.org/10.2147/hp.s130526
Vancouver
Seeley TW, Sternlicht MD, Klaus SJ, Neff TB, Liu DY. Induction of erythropoiesis by hypoxia-inducible factor prolyl hydroxylase inhibitors without promotion of tumor initiation, progression, or metastasis in a VEGF-sensitive model of spontaneous breast cancer. Hypoxia. 2017. doi:10.2147/hp.s130526
BibTeX
@article{Seeley2017,
author = {Seeley, Todd W and Sternlicht, Mark D and Klaus, Stephen J and Neff, Thomas B and Liu, David Y},
title = {Induction of erythropoiesis by hypoxia-inducible factor prolyl hydroxylase inhibitors without promotion of tumor initiation, progression, or metastasis in a VEGF-sensitive model of spontaneous breast cancer},
journal = {Hypoxia},
year = {2017},
doi = {10.2147/hp.s130526}
}
EUVIMED